183 related articles for article (PubMed ID: 38053165)
1. Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Nikolaienko O; Eikesdal HP; Ognedal E; Gilje B; Lundgren S; Blix ES; Espelid H; Geisler J; Geisler S; Janssen EAM; Yndestad S; Minsaas L; Leirvaag B; Lillestøl R; Knappskog S; Lønning PE
Genome Med; 2023 Dec; 15(1):104. PubMed ID: 38053165
[TBL] [Abstract][Full Text] [Related]
2. Constitutional
Al-Moghrabi N; Al-Showimi M; Alqahtani A; Almalik O; Alhusaini H; Almalki G; Saad A; Alsunayi E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542081
[TBL] [Abstract][Full Text] [Related]
3. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract][Full Text] [Related]
4. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
Al-Moghrabi N; Al-Showimi M; Al-Yousef N; Al-Shahrani B; Karakas B; Alghofaili L; Almubarak H; Madkhali S; Al Humaidan H
Clin Epigenetics; 2018 Jul; 10(1):99. PubMed ID: 30049288
[TBL] [Abstract][Full Text] [Related]
5. Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan.
Muhammad N; Azeem A; Bakar MA; Prajzendanc K; Loya A; Jakubowska A; Hamann U; Rashid MU
Breast Cancer Res Treat; 2023 Nov; 202(2):377-387. PubMed ID: 37528266
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Schwartz M; Ibadioune S; Vacher S; Villy MC; Trabelsi-Grati O; Le Gall J; Caputo SM; Delhomelle H; Warcoin M; Moncoutier V; Bourneix C; Boutry-Kryza N; De Pauw A; Stern MH; Buecher B; Mouret-Fourme E; Colas C; Stoppa-Lyonnet D; Masliah-Planchon J; Golmard L; Bieche I
Breast; 2024 Feb; 73():103620. PubMed ID: 38096711
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers.
Tian T; Shan L; Yang W; Zhou X; Shui R
Hum Pathol; 2019 Feb; 84():231-238. PubMed ID: 30339969
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
Prajzendanc K; Domagała P; Hybiak J; Ryś J; Huzarski T; Szwiec M; Tomiczek-Szwiec J; Redelbach W; Sejda A; Gronwald J; Kluz T; Wiśniowski R; Cybulski C; Łukomska A; Białkowska K; Sukiennicki G; Kulczycka K; Narod SA; Wojdacz TK; Lubiński J; Jakubowska A
Int J Cancer; 2020 Mar; 146(5):1293-1298. PubMed ID: 31469414
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
[TBL] [Abstract][Full Text] [Related]
12. Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer.
Morizono A; Tanabe M; Ikemura M; Sasaki T; Ushiku T; Seto Y
J Hum Genet; 2021 Aug; 66(8):785-793. PubMed ID: 33640902
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Gupta S; Jaworska-Bieniek K; Narod SA; Lubinski J; Wojdacz TK; Jakubowska A
Breast Cancer Res Treat; 2014 Dec; 148(3):615-22. PubMed ID: 25376744
[TBL] [Abstract][Full Text] [Related]
15. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
16. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.
Hansmann T; Pliushch G; Leubner M; Kroll P; Endt D; Gehrig A; Preisler-Adams S; Wieacker P; Haaf T
Hum Mol Genet; 2012 Nov; 21(21):4669-79. PubMed ID: 22843497
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy.
Kawachi A; Yamashita S; Okochi-Takada E; Hirakawa A; Tsuda H; Shimomura A; Kojima Y; Yonemori K; Fujiwara Y; Kinoshita T; Ushijima T; Tamura K
Breast Cancer Res Treat; 2020 Jun; 181(2):323-329. PubMed ID: 32314111
[TBL] [Abstract][Full Text] [Related]
19. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
[TBL] [Abstract][Full Text] [Related]
20. Constitutional Mosaic Epimutations - a hidden cause of cancer?
Lønning PE; Eikesdal HP; Løes IM; Knappskog S
Cell Stress; 2019 Mar; 3(4):118-135. PubMed ID: 31225507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
